Age-related differences in amphetamine sensitization: effects of prior drug or stress history on stimulant sensitization in juvenile and adult rats.
Repeated intermittent exposure to stimulants progressively increases a drug's effect, with stressors capable of producing cross-sensitization to stimulants. Studies examining such sensitization during development are few, however, with results mixed. In Experiment 1, juvenile (P22) and adult (P64) female Sprague-Dawley rats were administered (daily for 4days) 1.5mg/kg or 3.0mg/kg amphetamine (1.5A and 3.0A groups), or saline (SAL group). In a second experiment, rats were exposed to either repeated restraint (60min/day for 4days; RS group) or were left non-manipulated in the home cage (NM group). Animals from both experiments were then challenged with 1.5mg/kg of amphetamine and sensitization assessed via locomotion and stereotypy after a 2-day and 3-wk washout period. When compared to SAL animals, 3.0A juveniles and adults exhibited evidence of locomotor sensitization 2days post-drug exposure, but this sensitization did not persist to the 3-week challenge. Compared to NM animals, RS animals showed stress-induced locomotor sensitization both 2days and 3weeks post-stress exposure, regardless of age. These results demonstrate that repeated drug/stress exposures prior to stimulant challenge are sufficient to induce behavioral sensitization among both juveniles and adults, with these effects particularly long-lasting following repeated stressor exposure.
Doremus-Fitzwater
Tamara L
TL
Center for Development and Behavioral Neuroscience, Department of Psychology, Binghamton University, Binghamton, New York 13902-6000, USA.
Spear
Linda P
LP
D000367:Age Factors; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D005260:Female; D008124:Locomotion / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013239:Stereotyped Behavior / Q000187:drug effects; D013315:Stress, Psychological / Q000523:psychology*; D013997:Time Factors
D000697:Central Nervous System Stimulants; D000661:Amphetamine
Pharmacol Biochem Behav. 2007 Jan;86(1):92-102
17270257
Psychopharmacology (Berl). 1984;84(3):431-5
6440192
Neuroscience. 2002;113(2):395-400
12127096
Pharmacol Biochem Behav. 1997 Sep;58(1):9-14
9264063
Neurosci Biobehav Rev. 1999 Nov;23(7):993-1010
10580313
J Neurosci. 1999 Nov 1;19(21):9579-86
10531460
Pharmacol Biochem Behav. 1992 Sep;43(1):307-13
1409816
Br J Pharmacol. 1992 Apr;105(4):849-56
1504716
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
8401595
Brain Res. 1998 Feb 2;783(1):133-42
9479062
Annu Rev Psychol. 2003;54:25-53
12185211
Physiol Behav. 2005 Jan 17;83(5):805-11
15639166
Dev Psychobiol. 2008 Jul;50(5):451-9
18551462
Drug Discov Today Dis Models. 2008 Winter;5(4):259-270
20016773
Neurosci Biobehav Rev. 1998 Mar;22(2):347-54
9579324
Horm Behav. 2004 Nov;46(4):458-66
15465532
Horm Behav. 2005 Jun;48(1):64-74
15919386
Psychopharmacology (Berl). 1990;100(3):377-82
2315435
Neurotoxicol Teratol. 1992 May-Jun;14(3):221-8
1635542
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
18640920
J Pharmacol Exp Ther. 1995 Oct;275(1):345-57
7562570
Dev Psychobiol. 1983 Mar;16(2):83-109
6339302
Neuropharmacology. 1985 Sep;24(9):823-9
4058677
Brain Res. 1986 Jun;396(2):157-98
3527341
Psychopharmacology (Berl). 2009 Jan;201(4):589-99
18797848
Science. 1983 Mar 4;219(4588):1091-3
6681679
Pharmacol Biochem Behav. 1980 Dec;13(6):777-80
7208545
Pharmacol Biochem Behav. 1986 May;24(5):1225-8
3725828
Psychopharmacology (Berl). 1991;103(4):480-92
2062986
Brain Res Dev Brain Res. 2002 Sep 20;138(1):27-34
12234655
Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):163-78
12732232
Psychopharmacology (Berl). 1984;84(4):466-75
6441946
Brain Res Dev Brain Res. 1998 Nov 1;111(1):25-33
9804875
Pharmacol Biochem Behav. 2005 Oct;82(2):280-8
16199081
Neuropsychopharmacology. 2007 Mar;32(3):625-37
16794567
Psychopharmacology (Berl). 2005 Dec;183(2):218-25
16175404
Behav Neurosci. 1998 Oct;112(5):1152-66
9829793
Behav Brain Res. 2006 Sep 25;172(2):360-4
16822557
Neuroscience. 1999;92(1):343-52
10392855
Eur J Pharmacol. 2010 Feb 10;627(1-3):150-5
19879869
Int J Neuropsychopharmacol. 2006 Aug;9(4):377-92
16316481
Science. 1980 Jan 18;207(4428):329-31
7188649
Brain Res. 1990 Apr 23;514(1):22-6
2357527
Psychopharmacology (Berl). 1982;76(4):310-5
6812103
Pharmacol Biochem Behav. 1999 Jun;63(2):263-9
10371655
Addict Biol. 2005 Sep;10(3):251-6
16109586
Pharmacol Biochem Behav. 2001 Jan;68(1):115-24
11274716
Yakubutsu Seishin Kodo. 1992 Feb;12(1):17-25
1414027
Behav Neurosci. 2008 Aug;122(4):861-75
18729640
Psychopharmacology (Berl). 2008 May;198(1):51-62
18415082
Pharmacol Biochem Behav. 1998 Aug;60(4):909-14
9700975
Brain Res. 1992 Dec 11;598(1-2):343-8
1486498
Neuroscience. 2004;123(4):857-65
14751279
Life Sci. 1985 Sep 16;37(11):1039-42
4041000
Psychopharmacology (Berl). 1999 Feb;142(2):200-8
10102773
Physiol Behav. 2002 Aug;76(4-5):457-63
12126980
Dev Psychobiol. 2008 Mar;50(2):127-33
18286579